Overview

Comparison of Two Insulin Detemir Formulations in Healthy Volunteers

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare two formulations of insulin detemir containing an isotonic agent in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Glycerol
Insulin
Insulin Detemir
Insulin, Globin Zinc
Mannitol